Alemtuzumab Market

Alemtuzumab is a medication used to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis. In CLL, it has been used as both a first line and second line treatment. In MS it is generally only recommended if other treatments have not worked. It is given by injection into a vein.It is a monoclonal antibody that binds to CD52, a protein present on the surface of mature lymphocytes, but not on the stem cells from which these lymphocytes are derived. After treatment with alemtuzumab, these CD52-bearing lymphocytes are targeted for destruction.
Alemtuzumab Market contains market size and forecasts of Alemtuzumab in global, including the following market information:
Global Alemtuzumab Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Alemtuzumab Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Alemtuzumab companies in 2021 (%)
The global Alemtuzumab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Patent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Alemtuzumab include BOC Sciences, BOCSCI, Carbosynth, Sanofi, TargetMol Chemicals, DC Chemicals, Hefei Hirisun Pharmatech, Hubei Zhongshan Medical Technology and Jiangxi Ruiweier Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Alemtuzumab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alemtuzumab Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Alemtuzumab Market Segment Percentages, by Type, 2021 (%)
Patent
Generic
Global Alemtuzumab Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Alemtuzumab Market Segment Percentages, by Application, 2021 (%)
Chronic Lymphocytic Leukemia (CLL)
Multiple Sclerosis(MS)
Global Alemtuzumab Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Alemtuzumab Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alemtuzumab revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Alemtuzumab revenues share in global market, 2021 (%)
Key companies Alemtuzumab sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Alemtuzumab sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BOC Sciences
BOCSCI
Carbosynth
Sanofi
TargetMol Chemicals
DC Chemicals
Hefei Hirisun Pharmatech
Hubei Zhongshan Medical Technology
Jiangxi Ruiweier Biotechnology
Nantong Feiyu Biological Technology
Shanghai Loulan Biotechnology
Shanghai Macklin Biochemical
Shanghai Minkai Biotechnology
Shanghai Ruihui Chemical Technology
Shanghai Saimai Biotechnology
Shanghai Yifei Biotechnology
Taizhou KEDE Chemical
Wuhan Dingxintong Pharmaceutical
Wuhan Fortuna Chemical
Wuhan Weisman Bioengineering